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Introduction
Deficiency of adenosine deaminase-2 (ADA2) is a
recently described autoinflammatory disorder with cuta-
neous inflammatory disease, febrile episodes, cytopenias,
splenomegaly and early-onset stroke. Several homozy-
gous and compound heterozygous mutations in CECR1
have been reported in these patients; however, patho-
genesis is still poorly understood.
Objective
To determine the genotype - phenotype association in
patients with ADA2 deficiency due to identical homozy-
gous R169Q mutations in CECR1.
Methods
We performed a cohort study in nine patients diagnosed
with ADA2 deficiency due to a homozygous R169Q
mutation in the Netherlands and Belgium. Clinical and
diagnostic data were collected from clinical files. We
performed genealogy and haplotype analyses and mea-
sured serum ADA2 activity. ADA2 activity values were
correlated to clinical symptoms.
Results
Age of presentation differed widely between patients
(range: 0 mths to 8 yrs). The main clinical manifestations
were (hepato)splenomegaly (9/9); skin involvement (8/9)
and neurological involvement (8/9, of whom 6 encoun-
tered stroke). Considerable variation was seen in type,
frequency and intensity of other symptoms, which
included aplastic anemia, acute myeloid leukemia and
cutaneous ulcers. Common laboratory abnormalities
included cytopenias and hypogammaglobulinemia. ADA2
enzyme activity in patients was significantly decreased
compared to healthy controls (0.78 vs 5.41 IU/L, p <
0.0001). Within the patient cohort, ADA2 activity levels
tended to be lower in patients with stroke compared to
patients without stroke (0.30 vs 1.57 IU/L, p= 0.064). No
common ancestor for all families could be detected by
genealogy, however, based on allele frequency, a Dutch
founder effect can be noted. Three patients underwent
hematopoietic cell transplantation, after which ADA2
activity was restored and clinical symptoms resolved.
Conclusions
This study revealed large phenotypic variability in patients
with ADA2 deficiency though they carried the same
homozygous R169Q mutation in CECR1. Epigenetic and
environmental factors thus seem important in the pheno-
type. A trend towards a relation between stroke risk and
low ADA2 residual activity was seen. Furthermore, hema-
topoietic stem cell transplantation appears promising for
those patients with a severe clinical phenotype.
Authors’ details
1University Medical Center Utrecht, Pediatric Immunology and Infectious
Diseases, Utrecht, Netherlands. 2University Medical Center Utrecht, Child
Neurology, Utrecht, Netherlands. 3University Medical Center Utrecht, Medical
Genetics, Utrecht, Netherlands. 4Academic Medical Center, Amsterdam
Rheumatology and immunology Center, Amsterdam, Netherlands.
5Academic Medical Center, Neurology, Amsterdam, Netherlands. 6Leiden
University Medical Center, Pediatrics, Leiden, Netherlands. 7University Medical
Center Groningen, Paediatrics, Groningen, Netherlands. 8University Hospital
* Correspondence: M.E.vanGijn@umcutrecht.nl
3University Medical Center Utrecht, Medical Genetics, Utrecht, Netherlands
Full list of author information is available at the end of the article
Van Montfrans et al. Pediatric Rheumatology 2015, 13(Suppl 1):O7
http://www.ped-rheum.com/content/13/S1/O7
© 2015 Van Montfrans et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Leuven, Paediatrics, Leuven, Belgium. 9University Hospital Leuven,
Microbiology and Immunology, Leuven, Belgium. 10University Medical Center
Utrecht, Rheumatology and Clinical Immunology, Utrecht, Netherlands.
11University Medical Center Utrecht, U-DAIR, Laboratory of Translational
Immunology, Utrecht, Netherlands.
Published: 28 September 2015
doi:10.1186/1546-0096-13-S1-O7
Cite this article as: Van Montfrans et al.: Phenotypic variability in
patients with ADA2 deficiency due to identical homozygous R169Q
mutations. Pediatric Rheumatology 2015 13(Suppl 1):O7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Van Montfrans et al. Pediatric Rheumatology 2015, 13(Suppl 1):O7
http://www.ped-rheum.com/content/13/S1/O7
Page 2 of 2
